SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?


To: Jenna who wrote (22132)1/15/1999 10:14:00 AM
From: Master Trader  Respond to of 120523
 
NSTK viagra nasal spray.....good hold for three day weekend

Reuters is reporting that two researchers say that they have adapted Pfizer's PFE hugely successful Viagra for nasal delivery that
they say works within 5 minutes- up to 12 times faster than the pill form of the anti-impotence drug.

"Anwar Hussein, a researcher at the University of Kentucky College of Pharmacy, said he and colleague Lewis Dittert have
developed a soluble version of Pfizer Inc's(NYSE:PFE - news) blockbuster drug and want to license it to the pharmaceuticals giant.
''Sometimes patients taking Viagra are embarrassed because they wait an hour or longer and still there's no effect (erection),
especially if they've taken the pill with
meals,'' Hussein told Reuters. Frustrated patients then sometimes take another Viagra pill in hopes of speeding the effect, a
double-dosing that creates the risk of adverse side effects, Hussein said.

''The key was to find how to make Viagra very water soluble so the dissolved drug can be used through the nose,'' Hussein said.
Hussein said they hoped to persuade New York-based Pfizer to license their discovery and test it in humans."Our version will be so
quick and convenient to use and would definitely be more popular than the pills, which just take too long to work.And it will
minimize toxicity by eliminating the urge to double dose,'' he said."
Pfizer spokeswoman Mariann Caprino said she was not sure whether the scientists had yet approached company executives with
their proposal, or how it might be
received." biz.yahoo.com

There is one small cap that may capture the market's attention as a way for speculators to get an early jump on the possibility of a
Viagra nasal spray.Nastech Pharmaceuticals is recognized worldwide as the foremost leader in nasal drugdelivery. The company
has R&D collaborations and commercial partnerships to develop nasal delivery systems with several major pharmaceutical
companies, including Bristol-Myers Squibb, Dupont-Merck, and Schwarz Pharma and you guessed ....Pfizer.
techmall.com

Songwire notes that NSTK already has development for a nasal delivery system for erectile dysfunction already underway -

"Nastech recently expanded its product development program to include nasally administered drugs that act via the central nervous
system. The company said its initial emphasis will be in the areas of pain management and erectile dysfunction. "
biz.yahoo.com

In addition,the company has expanded its proprietary franchise in nasal technology to include 10 patents covering the nasal delivery
of 65 compounds and an
additional 3 patents pending.

PFE trading up 114 NSTK trading 4s- low end of its 52 week range of 3-14; expect the market to 'sniff' this one out



To: Jenna who wrote (22132)1/15/1999 11:44:00 AM
From: Jenna  Read Replies (2) | Respond to of 120523
 
e-mail: RNWK.. now bullish. I have tentative date as 27th january.. this company is reducing its negative earnings every quarter. stock looks good. making a deal with ATHM.. should influence its price action before the earnings report. Indicators were showing RNWK was on a strong uptrend for January.. until the RSI dropped and now has turned up positively once again.. RNWK has surprised the street in the 4 out of 4 of the last earnings report. It's Price/book, price/sales are both in the 97th percentile compared with all other stocks.

@HOME NETWORK AND REALNETWORKS TEAM TO CREATE NEXT GENERATION BROADBAND

Streaming Media Delivery Platform

New Broadband Features Leverage RealSystem G2's Open, Standards-Based, Architecture to Enable the First Wide-Scale Deployment of Broadband Streaming

Media Programming


REDWOOD CITY, Calif. and SEATTLE, Jan. 15 /PRNewswire/ -- @Home
Network (Nasdaq: ATHM), the leading provider of broadband Internet services via the cable infrastructure, and RealNetworks, Inc., (Nasdaq: RNWK) the recognized leader in streaming media, today announced an agreement to develop the first end to end, next generation broadband streaming media platform, to deliver unprecedented media experiences to consumers. This new broadband media delivery platform is based on RealNetworks RealSystem(TM) G2 and will incorporate new features designed to enable high quality, reliable and scalable high-bandwidth streaming media in a distributed network.